Eli Lilly Japan — Revenue decreased by 12.8% to $571.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 42.0%, from $402.00M to $571.00M. Over 4 years (FY 2021 to FY 2025), Japan — Revenue shows relatively stable performance with a -2.6% CAGR.
lly_segment_jp_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $665.40M | $595.00M | $534.80M | $410.20M | $454.40M | $487.70M | $395.00M | $387.20M | $455.60M | $390.80M | $439.40M | $363.90M | $462.70M | $429.10M | $559.30M | $402.00M | $521.00M | $554.70M | $654.80M | $571.00M |
| QoQ Change | — | -10.6% | -10.1% | -23.3% | +10.8% | +7.3% | -19.0% | -2.0% | +17.7% | -14.2% | +12.4% | -17.2% | +27.2% | -7.3% | +30.3% | -28.1% | +29.6% | +6.5% | +18.0% | -12.8% |
| YoY Change | — | — | — | — | -31.7% | -18.0% | -26.1% | -5.6% | +0.3% | -19.9% | +11.2% | -6.0% | +1.6% | +9.8% | +27.3% | +10.5% | +12.6% | +29.3% | +17.1% | +42.0% |